Michael F. Green, PhD, affiliated with the University of California, Los Angeles, has published extensively on schizophrenia, schizoaffective disorders, and bipolar disorder. His work focuses on cognitive impairment, social cognition, and their impact on functional outcomes in these conditions. He has also explored psychosocial interventions and the effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. His research has appeared in Psychiatrist.com from 2004 through 2025.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
